Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 38 (HNRNPA1P38) is a member of the large class of human pseudogenes derived from the heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) gene. Pseudogenes are DNA sequences that resemble functional genes but typically do not encode active, translated proteins. While some pseudogenes can be transcribed into RNA and may exert regulatory effects at the RNA level, the majority are not actively expressed or do not have detectable biological activity. There is no evidence to date that HNRNPA1P38 encodes a functional protein or participates directly in signal transduction, cell cycle, apoptosis, or other key biological processes associated with therapeutic targets. Consequently, HNRNPA1P38 is not considered a receptor, enzyme, transporter, or therapeutic target, nor is it implicated in known disease mechanisms, drug interactions, biomarker applications, or safety concerns.
None (no actionable protein, enzyme, receptor)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 38 (HNRNPA1P38).